| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2023 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 11,918 | $20.04 | $238,885.12 | -2.5% | -0.4% | +48.9% | |
| Aug 31, 2023 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 11,955 | $20.05 | $239,708.39 | -1.5% | -0.4% | +48.9% | |
| Aug 30, 2023 | WST West Pharmaceutical Services Inc | Favorite Annette F | Sr. VP &Chief Hr Officer | Sell | 2,000 | $414.64 | $829,276.85 | -6.1% | -13.8% | -23.0% | |
| Aug 30, 2023 | TMO Thermo Fisher Scientific Inc. | Pettiti Gianluca63 | Executive Vice President | Sell | 3,000 | $557.77 | $1,673,310.00 | -14.6% | -13.1% | +9.4% | |
| Aug 30, 2023 | BIO Bio-Rad Laboratories, Inc. | Ernst Timothy S69 | EVP, General Counsel &Sec | Sell | 2,350 | $395.60 | $929,666.76 | -19.7% | -23.3% | -15.9% | |
| Aug 28, 2023 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 10,299 | $33.62 | $346,296.67 | -4.6% | -17.8% | -31.9% | |
| Aug 24, 2023 | CRL Charles River Laboratories International, Inc. | Wallman Richard F81 | Director | Buy | 1,000 | $198.79 | $198,786.00 | New | -1.8% | +3.3% | |
| Aug 23, 2023 | BIO Bio-Rad Laboratories, Inc. | Ernst Timothy S69 | EVP, General Counsel &Sec | Sell | 300 | $384.69 | $115,407.00 | -11.0% | -20.7% | -19.7% | |
| Aug 23, 2023 | A Agilent Technologies, Inc. | Gonsalves Rodney65 | V.p., Corporate Controller | Sell | 3,500 | $118.78 | $415,716.00 | -12.6% | +4.0% | +17.7% | |
| Aug 23, 2023 | BDSX Biodesix Inc | Schuler Jack W45 | - | Buy | 128,363 | $1.69 | $216,509.94 | +0.1% | -24.1% | +1.1% | |
| Aug 22, 2023 | WST West Pharmaceutical Services Inc | Reiss-Clark Cindy | Chief Commercial Officer | Sell | 3,477 | $393.34 | $1,367,643.18 | -44.6% | -11.2% | -22.5% | |
| Aug 21, 2023 | EXAS Exact Sciences Corp | Elliott Jeffrey Thomas79 | Chief Financial Officer | Sell | 30,210 | $82.92 | $2,505,013.20 | -100% | -18.2% | -28.5% | |
| Aug 21, 2023 | DHR Danaher Corp /de/ | Gutierrez-Ramos Jose-Carlos | SVP, Chief Science Officer | Sell | 590 | $250.54 | $147,818.60 | -7.8% | -15.6% | +8.6% | |
| Aug 17, 2023 | WGS Genedx Holdings Corp. | Pfenniger Richard C Jr62 | Director | Buy | 5,000 | $5.10 | $25,523.00 | +84.5% | -74.9% | +572.6% | |
| Aug 17, 2023 | PMDI Psychemedics Corp | Doucot Charles M | Executive Vice President | Sell | 12,700 | $4.66 | $59,182.00 | -35.3% | - | - | |
| Aug 17, 2023 | FLGT Fulgent Genetics, Inc. | Gao Hanlin73 | Chief Scientific Officer | Sell | 342 | $33.88 | $11,587.34 | - | -19.7% | -31.6% | |
| Aug 17, 2023 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 1,798 | $33.88 | $60,918.22 | -0.4% | -19.7% | -31.6% | |
| Aug 17, 2023 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 100,000 | $1.76 | $175,803.71 | - | -18.4% | -10.9% | |
| Aug 17, 2023 | FLGT Fulgent Genetics, Inc. | Xie Jian77 | President And COO | Sell | 1,307 | $33.88 | $44,282.60 | -0.3% | -19.7% | -31.6% | |
| Aug 14, 2023 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 75,000 | $1.75 | $131,259.64 | - | -26.9% | -13.1% | |
| Aug 14, 2023 | MEDP Medpace Holdings, Inc. | Kraft Robert O.51 | - | Sell | 13,782 | $265.67 | $3,661,463.94 | -98.7% | +3.9% | +44.6% | |
| Aug 14, 2023 | CDNA Caredx, Inc. | Seeto Reginald76 | See Remarks | Sell | 576 | $8.89 | $5,122.66 | -0.1% | -15.2% | +195.5% | |
| Aug 11, 2023 | WST West Pharmaceutical Services Inc | Lai Quintin J68 | VP Strat &Investor Relations | Sell | 21,101 | $395.12 | $8,337,486.81 | -23.9% | -14.8% | -27.0% | |
| Aug 11, 2023 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 2,578 | $55.00 | $141,790.00 | -1.2% | -19.2% | +103.8% | |
| Aug 10, 2023 | CRL Charles River Laboratories International, Inc. | Knell Michael Gunnar67 | Csvp&Chief Accounting Officer | Sell | 1,471 | $216.54 | $318,530.34 | -12.9% | -19.1% | -7.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.